XTL Biopharmaceuticals Ltd. announced that Mr. Alex Rabinovich has been appointed as a member of the company's board of directors. Mr. Rabinovich is a leading investor in XTL and holds over 20% of its shares. Mr. Rabinovich will replace Mr. David Bassa, who has resigned from his position as a director of the Company, after serving as a director for seven years.